CureVac NV
NASDAQ:CVAC

Watchlist Manager
CureVac NV Logo
CureVac NV
NASDAQ:CVAC
Watchlist
Price: 5.05 USD -1.37% Market Closed
Market Cap: 1.1B USD

Wall Street
Price Targets

CVAC Price Targets Summary
CureVac NV

Wall Street analysts forecast CVAC stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CVAC is 4.78 USD with a low forecast of 2.02 USD and a high forecast of 5.78 USD.

Lowest
Price Target
2.02 USD
60% Downside
Average
Price Target
4.78 USD
5% Downside
Highest
Price Target
5.78 USD
14% Upside
CureVac NV Competitors:
Price Targets
ASND
Ascendis Pharma A/S
21% Upside
GOSS
Gossamer Bio Inc
167% Upside
ORKA
Oruka Therapeutics Inc
58% Upside
LGND
Ligand Pharmaceuticals Inc
28% Upside
AGIO
Agios Pharmaceuticals Inc
20% Upside
PTCT
PTC Therapeutics Inc
10% Upside
397030
AprilBio Co Ltd
9% Upside
BMEA
Biomea Fusion Inc
406% Upside

Revenue
Forecast

Revenue Estimate
CureVac NV

For the last 5 years the compound annual growth rate for CureVac NV's revenue is 98%. The projected CAGR for the next 4 years is -22%.

98%
Past Growth
-22%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
CureVac NV

The compound annual growth rate of CureVac NV's operating income for the next 4 years is -27%.

N/A
Past Growth
-27%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
CureVac NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CVAC's stock price target?
Price Target
4.78 USD

According to Wall Street analysts, the average 1-year price target for CVAC is 4.78 USD with a low forecast of 2.02 USD and a high forecast of 5.78 USD.

What is CureVac NV's Revenue forecast?
Projected CAGR
-22%

For the last 5 years the compound annual growth rate for CureVac NV's revenue is 98%. The projected CAGR for the next 4 years is -22%.

What is CureVac NV's Operating Income forecast?
Projected CAGR
-27%

The compound annual growth rate of CureVac NV's operating income for the next 4 years is -27%.

Back to Top